Loading
Loading
Vir Biotechnology ceo salary
Marianne De Backer, M.Sc., Ph.D., MBA President, Chief Executive Officer and Director of Vir Biotechnology, Inc. (VIR), received $7,834,045 ($7.8M) in total compensation for FY2025, down 15.4% from the prior year. Option awards of $3,507,360 were the largest component. Figures come from Vir Biotechnology, Inc.'s DEF 14A filed 16 Apr 2026 (accession 0001628280-26-025379).
Reported total from the latest DEF 14A pay table. Source filing (accession 0001628280-26-025379). These figures come from Vir Biotechnology, Inc.'s DEF 14A filed 16 Apr 2026 (accession 0001628280-26-025379).
| Component | Amount |
|---|---|
| Salary | $950,000 |
| Stock awards | $2,296,800 |
| Option awards | $3,507,360 |
| Cash incentive | $1,002,750 |
| Other | $77,135 |
| Total | $7,834,045 |
FAQ
See also: VIR ticker page